Adage Capital Partners
THC icon

Adage Capital Partners’s Tenet Healthcare THC Stock Holding History

Adage Capital Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7M Buy
238,848
+146,475
+159% +$26.9M 0.06% 304
2026
Q1 		$17.4M Sell
92,373
-99,481
-52% -$21M 0.03% 536
2025
Q4 		$38.1M Sell
191,854
-203,661
-51% -$41.2M 0.06% 316
2025
Q3 		$80.3M Buy
395,515
+38,540
+11% +$6.84M 0.13% 161
2025
Q2 		$62.8M Sell
356,975
-112,554
-24% -$16.9M 0.11% 187
2025
Q1 		$63.2M Buy
469,529
+247,314
+111% +$32.6M 0.12% 177
2024
Q4 		$28.1M Sell
222,215
-86,794
-28% -$12.9M 0.05% 349
2024
Q3 		$51.4M Buy
309,009
+9,368
+3% +$1.42M 0.09% 230
2024
Q2 		$39.9M Sell
299,641
-4,019
-1% -$484K 0.07% 266
2024
Q1 		$31.9M Sell
303,660
-13,508
-4% -$1.21M 0.06% 338
2023
Q4 		$24M Buy
+317,168
New +$20.1M 0.05% 374
2023
Q3 		– Sell
-279,673
Closed -$22.8M – 938
2023
Q2 		$22.8M Buy
279,673
+180,656
+182% +$12.9M 0.05% 374
2023
Q1 		$5.88M Buy
+99,017
New +$5.5M 0.01% 688
2016
Q3 		– Sell
-150,000
Closed -$4.15M – 727
2016
Q2 		$4.15M Sell
150,000
-100
-0.1% -$2.96K 0.01% 607
2016
Q1 		$4.34M Sell
150,100
-300
-0.2% -$7.8K 0.01% 613
2015
Q4 		$4.56M Sell
150,400
-698,900
-82% -$22.9M 0.01% 607
2015
Q3 		$31.4M Buy
849,300
+545,100
+179% +$28.2M 0.09% 293
2015
Q2 		$17.6M Buy
304,200
+147,000
+94% +$7.51M 0.04% 438
2015
Q1 		$7.78M Buy
157,200
+15,000
+11% +$701K 0.02% 586
2014
Q4 		$7.21M Sell
142,200
-277,600
-66% -$14.5M 0.02% 581
2014
Q3 		$24.9M Buy
419,800
+72,800
+21% +$4.06M 0.06% 342
2014
Q2 		$16.3M Sell
347,000
-323,039
-48% -$14.6M 0.04% 437
2014
Q1 		$28.7M Sell
670,039
-110,961
-14% -$4.9M 0.08% 299
2013
Q4 		$32.9M Buy
781,000
+475,000
+155% +$20.7M 0.09% 292
2013
Q3 		$12.6M Buy
+306,000
New +$12.8M 0.04% 460

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Adage Capital Partners's THC Position: Q2 2026 in Review

Adage Capital Partners increased its Tenet Healthcare (THC) stake by 159% in Q2 2026, buying an estimated $26.9M and bringing the position to 238,848 shares worth $44.7M. The position accounts for 0.06% of the portfolio, ranked #304.

Adage Capital Partners first reported a position in THC in Q3 2013 and has held it in 25 quarters since. The position peaked at $80.3M in Q3 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Adage Capital Partners held 238,848 shares of Tenet Healthcare worth $44.7M as of Q2 2026.
  • Adage Capital Partners bought 146,475 Tenet Healthcare shares in Q2 2026, an estimated $26.9M.
  • Tenet Healthcare made up 0.06% of Adage Capital Partners's portfolio in Q2 2026, its #304 holding.
  • Adage Capital Partners first reported a position in Tenet Healthcare in Q3 2013 and has held it in 25 quarters since.
  • Adage Capital Partners's Tenet Healthcare position peaked at $80.3M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.